Cutia Therapeutics (HKG:2487)
Hong Kong · Delayed Price · Currency is HKD 3.470
-0.220 (-5.96%)
May 28, 2026, 4:08 PM HKT
Cutia Therapeutics Market Cap
Cutia Therapeutics has a market cap or net worth of 1.26 billion as of May 28, 2026. Its market cap has decreased by -35.94% in one year.
Market Cap
1.26B
Enterprise Value
736.92M
Revenue
374.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.47
Market Cap Chart
Since June 12, 2023, Cutia Therapeutics's market cap has decreased from 6.67B to 1.26B, a decrease of -81.11%. That is a compound annual growth rate of -43.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 1.26B | -23.57% |
| Dec 31, 2025 | 1.65B | -26.86% |
| Dec 31, 2024 | 2.26B | -32.43% |
| Dec 29, 2023 | 3.34B | -49.98% |
| Jun 12, 2023 | 6.67B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SinoMab BioScience | 1.80B |
| Mabpharm | 1.65B |
| Frontage Holdings | 1.56B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.52B |
| Beijing Biostar Pharmaceuticals | 1.48B |
| Zhaoke Ophthalmology | 1.38B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.32B |
| Kintor Pharmaceutical | 1.14B |